Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_799b6c8cb40ea97102dceda7bfe7b5c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d4ad61d0af1fd483d31d1c5df9b9b76 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B20-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
filingDate |
2020-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29b551dc4317c9cc9a31098e5f36c36d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3df5a4f4eb289e2db82ece2d1eff85c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d5bb4d4c522cce88218bdd84f46fc49 |
publicationDate |
2021-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20210111054-A |
titleOfInvention |
Personalized prognostic prediction model of intermittent treatment for chronic myeloid leukemia |
abstract |
The present invention is an invention that can provide various technologies for establishing a patient-specific mathematical modeling that can predict the recurrence pattern after secondary discontinuation of imatinib in chronic myeloid leukemia patients, which are different for each patient. |
priorityDate |
2020-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |